MA 12.10 Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria

L. Barrera; J.R. Borbolla-Escoboza; E. Montes-Servin; E.O. Macedo-Perez; F. Barron; C. Molina Romero; J. Hernandez Martinez; O. Arrieta

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >MA 12.10 Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria

【24h】

MA 12.10 Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria

机译：MA 12.10血浆EGFR T790M突变检测在先进的非小细胞肺癌患者中的临床效用，根据Recist标准

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第11期|共1页
作者
L. Barrera; J.R. Borbolla-Escoboza; E. Montes-Servin; E.O. Macedo-Perez; F. Barron; C. Molina Romero; J. Hernandez Martinez; O. Arrieta;
展开▼
作者单位

Global Medical Affairs Astrazeneca;

Medical Affairs Astrazeneca;

Functional Unit of Thoracic Oncology and Laboratory of Personalized Medicine Instituto Nacional de;

Functional Unit of Thoracic Oncology and Laboratory of Personalized Medicine Instituto Nacional de;

Functional Unit of Thoracic Oncology and Laboratory of Personalized Medicine Instituto Nacional de;

Functional Unit of Thoracic Oncology and Laboratory of Personalized Medicine Instituto Nacional de;

Functional Unit of Thoracic Oncology and Laboratory of Personalized Medicine Instituto Nacional de;

Functional Unit of Thoracic Oncology and Laboratory of Personalized Medicine Instituto Nacional de;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 第一代酪氨酸激酶抑制剂治疗中发生进展的非小细胞肺癌血浆表皮生长因子受体(EGFR) T790M突变提示了失败部位并预测了临床预后:一项前瞻性观察研究 [J] . Shirong Zhang, Lucheng Zhu, Bing Xia, 癌症（英文版） . 2018,第009期
2. MA 12.10 Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria [J] . L. Barrera, J.R. Borbolla-Escoboza, E. Montes-Servin, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：MA 12.10血浆EGFR T790M突变检测在先进的非小细胞肺癌患者中的临床效用，根据Recist标准
3. Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer [J] . Keigo Kobayashi, Katsuhiko Naoki, Tadashi Manabe, OncoTargets and therapy . 2018,第2期

机译：EGFR-TKI抗性非小细胞肺癌中血浆，血清和肿瘤组织 EGFR T790M突变检测方法的比较

4. Selective gene amplification to detect the T790M mutation in plasma from patients with advanced non-small cell lung cancer (NSCLC) who have developed epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance [J] . Shingo Nishikawa, Hideharu Kimura, Hayato Koba, Journal of Thoracic Disease . 2018,第3期

机译：选择性基因扩增可检测已发展为表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKI）耐药的晚期非小细胞肺癌（NSCLC）患者血浆中的T790M突变

5. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系

6. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性

7. Comparison of detection methods of EGFR T790M mutations using plasma serum and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer [O] . Keigo Kobayashi, Katsuhiko Naoki, Tadashi Manabe, 2018

机译：血浆血清和肿瘤组织检测EGFR-TKI耐药的非小细胞肺癌EGFR T790M突变的方法比较

8. 134O_PR: Plasma ctDNA analysis for detection of EGFR T790M mutation in patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (aNSCLC) [O] . S. Jenkins, J. Yang, S. Ramalingam, 2016

机译：134O_PR：具有EGFR突变阳性晚期非小细胞肺癌（ANSCLC）患者（PTS）患者EGFR T790M突变的血浆CTDNA分析

1. 血浆EGFR基因突变检测在晚期非小细胞肺癌患者EGFR-TKI疗效评估中的价值 [J] . 冯卫能 ,张华 ,陈泽程 . 山东医药 . 2017,第013期

2. 非小细胞肺癌患者外周血ctDNA中EGFR基因突变检测的临床意义 [J] . 陈学瑜 ,罗芳秀 ,赵广垠 . 山东医药 . 2019,第025期

3. 外周血EGFR突变检测在晚期非小细胞肺癌患者中的临床应用分析 [J] . 吴洪波 ,唐俊舫 ,李明智 . 中国医刊 . 2017,第005期

4. EGFR突变阳性晚期非小细胞肺癌患者厄洛替尼治疗前的EGFR T790M突变和BRCA1 mRNA表达 [J] . 周清 . 循证医学 . 2011,第1期

5. 664例非小细胞肺癌患者EGFR基因突变检测与临床特征关系研究 [C] . 闫小龙 ,李小飞 ,张志培 . 第13届全国肺癌学术大会 . 2013

6. 原发性EGFR T790M突变非小细胞肺癌患者临床特征研究 [A] . 张辉标 . 2014

1. 在肺癌患者中检测EGFR基因T790M突变的试剂盒 [P] . 中国专利： CN108517359A . 2018-09-11

2. 一种检测血浆游离DNA中EGFR基因T790M突变的引物对及试剂盒 [P] . 中国专利： CN112481366A . 2021-03-12

3. METHODS TO DETECT MUTATIONS IN PLASMA USING EXOSOMAL RNA AND CELL FREE DNA FROM NON-SMALL CELL LUNG CANCER PATIENTS [P] . 外国专利： EP3548635B1 . 2021-04-28

机译：使用来自非小细胞肺癌患者的外泌体RNA和无细胞DNA检测血浆中突变的方法

4. Methods and compositions to detect mutations in plasma using exosomal RNA and cell free DNA from non-small cell lung cancer patients [P] . 外国专利： AU2017366813A1 . 2019-06-13

机译：使用非小细胞肺癌患者的外泌体RNA和游离DNA检测血浆突变的方法和组合物

5. METHODS AND COMPOSITIONS TO DETECT MUTATIONS IN PLASMA USING EXOSOMAL RNA AND CELL FREE DNA FROM NON-SMALL CELL LUNG CANCER PATIENTS [P] . 外国专利： US2019376128A1 . 2019-12-12

机译：利用非小细胞肺癌患者的外泌体RNA和无细胞DNA检测血浆中突变的方法和成分

相关主题

MA 12.10 Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria

著录项

相似文献

相关主题

期刊订阅